SCHEMBL3115332

SCHEMBL3115332

CN(C)CCn1c(=O)n(CCCc2nc(Cc3ccc(F)cc3F)no2)c(=O)c2[nH]c(Cl)nc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 10/20 0.40
ADORA1 P30542 4/20 0.37
ADORA3 P0DMS8 1/20 0.37
MPO P05164 2/20 0.35
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
CYP1A2 P05177 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
ADRA2A P08913 1/20 0.34
CYP2D6 P10635 1/20 0.34
CHRM1 P11229 1/20 0.34
ADRA2B P18089 1/20 0.34
CHRM3 P20309 1/20 0.34
SLC6A2 P23975 1/20 0.34
ADRA1D P25100 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HRH1 P35367 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3118172 0.98 ADORA2B (0.40) ADORA2BADORA1ADORA3MPOALDH1A1
SCHEMBL837291 0.92 ADORA2B (0.48) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL837154 0.92 ADORA2B (0.43) ADORA2BADORA1ADORA3PCK1ADORA2A
SCHEMBL874355 0.92 ADORA2B (0.44) ADORA2BADORA1ADORA3PCK1ADORA2A
SCHEMBL837752 0.91 ADORA2B (0.44) ADORA2BADORA1ADORA3PCK1ADORA2A
SCHEMBL834086 0.91 ADORA2B (0.39) ADORA2BADORA1ADORA3PCK1ADORA2A
SCHEMBL2533939 0.91 ADORA2B (0.39) ADORA2BADORA1ADORA3PCK1ADORA2A
SCHEMBL836299 0.91 ADORA2B (0.39) ADORA2BADORA1ADORA3PCK1ADORA2A
SCHEMBL837212 0.90 ADORA2B (0.39) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL3118132 0.90 ADORA2B (0.38) ADORA2BADORA1ADORA3PCK1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 ADORA2B 111/4885ADORA1 32/4885ADORA3 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.